SD HEALTHCARE
Recent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...Congress Members, Researchers Push for More NIH Funding
U.S. Reps. Susan Davis and Scott Peters, both Democrats from San Diego, gathered with a group of the region’s medical research stakeholders to solicit Congress to increase funding for the National Institutes of Health, which funds much of the medical research taking place in this area.
March 21, 2014 2:18 p.m. $$ ShareThe JOBS Act Boosts Biotech Community’s Access to Investment
This month marks the second anniversary of President Barack Obama’s Jumpstart Our Business Startups, or JOBS, Act.
Scripps Advance to Fill Need for Speed in Pharma
BIOTECH: Goal Is to Quickly Get Research To Development Phase
The Scripps Research Institute has formed a new drug discovery company called Scripps Advance to fast-track the translation of early-stage biomedical research into clinical development and, ultimately, commercialization.
Life Sciences See Stock Spotlight Dim as Challenges Take Focus
Biotech: Ups and Downs A Common Reality Among Industry’s Local Public Cos.
Public companies in San Diego’s biotech industry have been on quite the roller coaster, a trend reflected in how that sector is represented in the San Diego Business Journal’s new list of the 50 largest local public companies, ranked by revenue in fiscal 2013.
Covered California Reports 1.4M Enrolled
HEALTH: Signups Surge at End; 88% Eligible for Subsidies
The final surge of Covered California signups ended April 15 with more than 1.4 million enrolled, vastly exceeding initial estimates, despite some confusion in the signup process. However, the number of small businesses enrolled in the exchange’s Small Business Health Options Program, or SHOP, was much lower — about 1,150 signed up, representing about 4,900 employees and their dependents.
Vital Therapies Launches IPO
Vital Therapies Inc. has hit the public markets, but has priced its stock below the expected range, raising gross proceeds of $54 million by offering 4.5 million shares at $12 apiece.
Nursing Care Facility in El Cajon Sold for $7.5 Million
Rocklin-based Auburn Manor Holding Corp. has purchased Chase Care Center, a skilled-nursing healthcare facility in El Cajon, for $7.5 million, according to CoStar Group and public data.
Zogenix Obtains Preliminary Injunction Against Massachusetts’ Ban of Painkiller
Zogenix Inc., the San Diego drugmaker embroiled in controversy over its new opioid painkiller Zohydro ER, finally has a win under its belt — it has successfully blocked an order from Massachusetts Governor Deval Patrick to ban the drug in that state.
BIO's Launches New System to Promote Cos. Connecting at June Convention
The Biotechnology Industry Organization, shortened to BIO, has launched its one-on-one partnering system that will help companies initiate private meetings and gain business contacts at its annual convention, which will be held this June in San Diego.
Senomyx’s Stock Gets a Boost from New Deal With PepsiCo
Stock for San Diego flavor maker Senomyx Inc. rose after signing a new deal with PepsiCo Inc. to develop chemicals that will “restore the desired salty taste in products with reduced salt.”
Incubator Gains Momentum, ‘Rock Stars’ Through Its Successes
Biotech: Janssen Labs Is Selective, Not Controlling Of Its Life Science Startups
A Torrey Pines-based life sciences incubator that began two years ago as an “experiment” by pharmaceutical and consumer product giant Johnson & Johnson has today shown more momentum than anyone back then would have imagined.
Genomatica Part of Biorenewables Pivot
Biotech: Lack of Market For Biofuels Spurs Flexibility
Biofuels don’t hold the same cachet or glamour they once had, but companies like San Diego’s Genomatica Inc. are showing that the market opportunity is still there for biorenewable products. In particular, specialty chemicals and nutritional supplements are proving to be economically viable industries in the sustainability space.
NuVasive Ordered to Pay $30M in Trademark Case
A jury has ordered medical device maker NuVasive Inc. to pay $30 million to Ventura-based NeuroVision Medical Products Inc. for infringing on the trademark “NeuroVision.”
Tech and Biotech Stocks Slump
Biotech and tech stocks have been in a slump for the past three weeks, evidenced in part by the 3.1 percent drop in the Nasdaq Composite — the worst one day percentage decline, according to MarketWatch, since November 2011.
FDA Puts Clinical Hold on Halozyme’s Pancreatic Cancer Treatment Trial
The Food and Drug Administration has halted the study of Halozyme Therapeutics Inc.’s pancreatic cancer treatment trial, just few days after the company voluntary stopped patient enrollment in the drug’s clinical trials.
Palomar Health Facing Possible $250,000 Fine for Data Breach
The California Department of Public Health could fine Palomar Health up to $250,000 in connection with the theft of flash drives containing patient data.
-
prev
- next
